1. Home
  2. PLRX vs ATRO Comparison

PLRX vs ATRO Comparison

Compare PLRX & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

N/A

Current Price

$1.11

Market Cap

73.7M

Sector

Health Care

ML Signal

N/A

Logo Astronics Corporation

ATRO

Astronics Corporation

N/A

Current Price

$67.62

Market Cap

3.5B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
PLRX
ATRO
Founded
2015
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
73.7M
3.5B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
PLRX
ATRO
Price
$1.11
$67.62
Analyst Decision
Hold
Strong Buy
Analyst Count
4
2
Target Price
$2.67
$86.00
AVG Volume (30 Days)
364.4K
454.9K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
29.97
276.09
EPS
N/A
1.31
Revenue
N/A
$862,128,000.00
Revenue This Year
N/A
$14.92
Revenue Next Year
N/A
$8.81
P/E Ratio
N/A
$50.86
Revenue Growth
N/A
8.39
52 Week Low
$1.02
$39.14
52 Week High
$1.95
$99.89

Technical Indicators

Market Signals
Indicator
PLRX
ATRO
Relative Strength Index (RSI) 48.64 34.89
Support Level $1.12 $63.78
Resistance Level $1.26 $79.86
Average True Range (ATR) 0.04 2.84
MACD -0.00 -0.90
Stochastic Oscillator 27.69 5.71

Price Performance

Historical Comparison
PLRX
ATRO

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

About ATRO Astronics Corporation

Astronics Corporation is a provider of technologies to the aerospace, defense, and electronics industries, offering high-performance electrical power generation and distribution systems, motion systems, lighting and safety systems, avionics products, systems certification, aircraft structures, and automated test systems. The company operates through two reportable segments, Aerospace and Test Systems. The Aerospace segment designs and manufactures products for the aerospace and defense industry and generates the majority of revenue, while the Test Systems segment designs, develops, manufactures, and maintains automated test systems for the aerospace and defense, communications, and mass transit industries. The company derives the majority of its revenue from the United States.

Share on Social Networks: